NASDAQ
Compass Therapeutics, Inc. (CMPX) has a free cash flow growth of -30.91% as of Friday, May 29, 2026. This represents a 159.45% decrease compared to its 12-month average of -11.91%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.